Michelle Doig

Michelle Doig

Fundador en OMEGA ALPHA SPAC .
52 años
Finance
Health Technology
Consumer Services

Perfil

Ms. Michelle Doig is an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a President & Director at Omega Alpha SPAC and a Partner & Head-Corporate Development at Omega Fund Management LLC.
She is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/, Artios Pharma Ltd., Omega Alpha SPAC and Nuvation Bio Operating Co., Inc. Ms. Doig was previously employed as a Director-Corporate Finance by Third Rock Ventures LLC, a Principal by Abingworth LLP, an Associate by Lehman Brothers, Inc., an Associate by J.P.
Morgan & Co., Inc. (Delaware), an Analyst by Morgan Stanley, and a Manager by Student Works Management Program.
She also served on the board at Nuvation Bio, Inc. She received her undergraduate degree from Richard Ivey School of Business.

Cargos activos de Michelle Doig

EmpresasCargoInicio
OMEGA ALPHA SPAC Fundador 01/11/2020
Inversor de Capital Privado 01/01/2016
Director/Miembro de la Junta -
Director/Miembro de la Junta 01/07/2021

Antiguos cargos conocidos de Michelle Doig.

EmpresasCargoFin
NUVATION BIO INC. Director/Miembro de la Junta 31/07/2021
Inversor de Capital Privado 31/12/2016
Corporate Officer/Principal 01/11/2013
Corporate Officer/Principal 01/01/2002
Corporate Officer/Principal 01/03/2001
Ver el detalle de la experiencia de Michelle Doig.

Formación de Michelle Doig.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

76

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Finance

Finance

Finance

Finance

Finance

Consumer Services

Health Technology

Finance

Health Technology

Finance

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN